Methods for technetium/rhenium labeling of proteins
AssigneeImmunomedics, Inc.
InventorsHans J. Hansen, Gary L. Griffiths, Anastasia Lentine-Jones
Life of this patent
Estimating the term…
Loading patent…
AssigneeImmunomedics, Inc.
InventorsHans J. Hansen, Gary L. Griffiths, Anastasia Lentine-Jones
Estimating the term…
A method for radiolabeling a protein with a radioisotope of technetium or rhenium is disclosed which comprises the steps of contacting a solution of a protein containing a plurality of adjacent free sulfhydryl groups, or in particular cases, intact protein containing at least one disulfide group, with stannous ions, and then with radiopertechnetate or radioperrhenate, the amount of stannous ion being sufficient to substantially completely reduce the radiopertechnetate or radioperrhenate, and recovering radiolabeled protein. A rapid and quantitative method for producing a sterile, injectable solution of Tc-99m-labeled monovalent antibody fragment is also disclosed which comprises the step of mixing a sterile solution containing a monovalent antibody fragment having at least one free sulfhydryl group, stannous chloride and excess tartrate, at mildly acidic pH, or a sucrose-stabilized lyophilizate of such solution, with a sterile solution of Tc-99m-pertechnetate, whereby substantially quantitative labeling of the antibody fragment with Tc-99m is effected in about 5 minutes at ambient temperature, the resultant sterile solution of Tc-99m-labeled monovalent antibody fragment being suitable for immediate injection into a patient for scintigraphic imaging.
A method for radiolabeling a protein with the Tc-99m radioisotope of technetium, comprising the steps of contacting a solution of about 0.1-5 mg/ml of an antibody or antibody fragment containing a plurality of adjacent free sulfhydryl groups with about 0.5-25 .mu.g/ml of stannous ions under an inert gas atmosphere, storage of the reduced antibody or antibody fragment under oxygen-free conditions, and then reacting with Tc-99m-radiopertechnetate, in the absence of a transchelator, and recovering radiolabeled protein.
A kit for radiolabeling an antibody or antibody fragment with the Tc-99m radioisotope of technitium, comprising in separate containers:
A method for radiolabeling a protein with substantially carrier-free Re-188 perrhenate, comprising the steps of contacting a solution of about 1-20 mg/ml of an antibody or antibody fragment containing a plurality of adjacent free sulfhydryl groups with about 100-10,000 .mu.g/ml of stannous ions under an inert gas atmosphere, storage of the reduced antibody or antibody fragment under oxygen-free conditions, and then with about 10-500 mCi of substantially carrier-free Re-188, and recovering radiolabeling protein.
A method for radiolabeling an intact antibody or a F(ab').sub.2 antibody fragment with a radioisotope of rhenium, comprising the steps of contacting a solution of an intact antibody or a F(ab').sub.2 antibody fragment containing at least one disulfide group and which specifically binds to an antigen produced by or associated with a tumor or infectious lesion, with stannous ions under an inter gas atmosphere, storage of the reduced antibody or antibody fragment under oxygen-free conditions, and then with radioperrhenate, without first subjecting said solution containing said intact antibody or a F(ab').sub.2 antibody fragment and stannous ions to a sizing column, the amount of stannous ion being in excess over that required to substantially completely reduce said radioperrhenate but not sufficient to precipitate from said solution, and recovering radiolabeled protein.
A kit for radiolabeling an antibody or antibody fragment with the Re-188 radioscope of rhenium, comprising in separate containers:
A method for radiolabeling a protein with carrier-added Re-186, comprising the steps of contacting a solution of about 1-20 mg/ml of protein containing a plurality of adjacent free sulfhydryl groups with about 1-1,000 mg/ml of stannous ions under an inert gas atmosphere, storage of the reduced protein under oxygen-free conditions, and then with about 10-500 mCi of carrier-added Re-186-perrhenate, and recovering radiolabeled protein.
A kit for radiolabeling an antibody or antibody fragment with the Re-186 radioisotope of rhenium, comprising in separate containers:
Dependencies are inferred from the claim text.